Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 1 5Phase NA 4Phase 4 3Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Vomiting 3Lymphoma, Mantle-Cell 2Neoplasms 1Nausea 1Lymphoma 1Leukemia, Mast-Cell 1Glioma 1

Interventions

Palonosetron 13Aprepitant 13Dexamethasone 11Ondansetron 10fosaprepitant 4Olanzapine 4Granisetron 3Calcium Dobesilate 3ramosetron 2netupitant 2Tropisetron 2Radiotherapy 2Fluorouracil 2rolapitant 1netupitant, palosentron drug combination 1ginger extract 1dolasetron 1casopitant 1Yoga 1Therapeutics 1Serotonin 5-HT3 Receptor Antagonists 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Pantoprazole 1Paclitaxel 1Oxaliplatin 1Octreotide 1Megestrol Acetate 1Megestrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Vomiting × Granisetron × Clear all
NCT00003817 2015-10-15

Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy

University of Rochester

Phase 2 Completed
700 enrolled

Nausea, Vomiting

NCT00450853 2015-01-27

Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients

Clinica Universidad de Navarra, Universidad de Navarra

Phase 2 Completed
31 enrolled

Vomiting

NCT00666783 2008-04-25

An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients

Xijing Hospital

Phase 2 Completed
208 enrolled

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡